LU X41 Pill - white round, 6mm
Pill with imprint LU X41 is White, Round and has been identified as Armodafinil 50 mg. It is supplied by Lupin Pharmaceuticals, Inc.
Armodafinil is used in the treatment of Shift Work Sleep Disorder; Narcolepsy; Obstructive Sleep Apnea/Hypopnea Syndrome and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Armodafinil 50 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for LU X41
Armodafinil
- Imprint
- LU X41
- Strength
- 50 mg
- Color
- White
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Lupin Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 68180-0569
- Inactive Ingredients
-
povidone k30,
sodium starch glycolate type A potato,
sodium stearyl fumarate,
lactose monohydrate,
corn starch
Note: Inactive ingredients may vary.
See also:
Nuvigil
Nuvigil may be used to improve wakefulness in adults who are very sleepy due to narcolepsy ...
Xywav
Xywav is used for the treatment of cataplexy and excessive daytime sleepiness (EDS) in patients ...
Provigil
Provigil promotes wakefulness and is used to treat excessive daytime sleepiness caused by ...
Xyrem
Xyrem (sodium oxybate) is an oral prescription solution that may be used to treat cataplexy or ...
Lumryz
Lumryz (sodium oxybate) is used for the treatment of patients with narcolepsy. Includes Lumryz side ...
Sodium oxybate
Sodium oxybate is used to treat narcolepsy symptoms, such as cataplexy or excessive daytime ...
More about armodafinil
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (439)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: CNS stimulants
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.